Medical Coverage Policy | as a Treatment of Joint Instability sad
Defines coverage position for thermal capsulorrhaphy as a treatment for joint instability (shoulder, knee, elbow, and other joints) for BlueCHiP for Medicare and Commercial products, including coding guidance for unlisted arthroscopy and HCPCS S2300.
No material clinical or coverage changes.
Coverage Summary
Thermal capsulorrhaphy for treatment of joint instability (including the shoulder, knee, elbow, and other joints) is considered not covered / not medically necessary (coverage stance: not_covered_cosmetic). Effective date: 2015-02-03; Last review: 2018-07-03.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.